Skip to content
Open access

Comparative Phytochemical and Antiviral Characteristics of Dipsacus asperoides and Phlomis umbrosa Against Influenza A Virus: LC-QTOF-MS Profiling and Exploratory Network Pharmacology

Aug 2026 · Plants · Vol 15, pp. 2649 · 0 citations · 42 references
Medicine

TL;DR

Despite clearly different phytochemical profiles, the two Sokdan species showed a shared pattern of modest in vitro antiviral response and should be interpreted as hypothesis-generating rather than mechanistic confirmation and suggest candidate host-response pathways that can guide targeted follow-up experiments.

Abstract

Background: Influenza A virus (IAV) remains an important respiratory pathogen, and medicinal plants continue to provide chemically diverse sources for antiviral research. Dipsacus asperoides and Phlomis umbrosa have both been used under the traditional name ‘Sokdan’ despite their distinct botanical origins and phytochemical compositions. This study comparatively characterized their chemical profiles and in vitro responses to IAV and used network pharmacology as an exploratory approach to identify candidate pathways for subsequent mechanistic studies. Methods: Ethanolic extracts were evaluated for cytotoxicity in MDCK cells, cytopathic effect (CPE) reduction against IAV A/PR/8/34 (H1N1), and neuraminidase (NA) inhibition. LC-QTOF-MS was used for qualitative chemical profiling, and species-specific compound sets were subjected to target prediction, protein–protein interaction analysis, and pathway enrichment. Results: D. asperoides was non-cytotoxic up to 100 µg/mL and P. umbrosa up to 300 µg/mL under the tested conditions. Both extracts produced modest CPE reduction, reaching maximum inhibition of 21.8 ± 1.4% at 100 µg/mL for D. asperoides and 17.1 ± 6.1% at 200 µg/mL for P. umbrosa, whereas zanamivir (5 µM) produced 76.2 ± 0.8% inhibition. NA inhibition was limited for both extracts. LC-QTOF-MS identified twelve constituents with distinct species-associated detection patterns, including phenylpropanoids, iridoid glycosides, and triterpenoid saponins. Exploratory network analysis identified partially overlapping predicted hubs, including MAPK1/3, RELA, IL-6, TNF, and CASP3, together with additional species-specific nodes. Conclusions: Despite clearly different phytochemical profiles, the two Sokdan species showed a shared pattern of modest in vitro antiviral response. The network pharmacology results should be interpreted as hypothesis-generating rather than mechanistic confirmation and suggest candidate host-response pathways that can guide targeted follow-up experiments. These findings support phytochemical differentiation of the two species while providing a comparative framework for future investigation of their antiviral properties.

Read PDF

Similar papers

Sep 2026

Investigating the phytochemical composition of Curcuma longa, Azadirachta indica, and Asparagus racemosus using network pharmacology and molecular docking approaches for ovarian cancer therapy

The study highlighted the therapeutic action of C. longa, A. indica, and A. racemosus in combating ovarian cancer and promoting the development of plant-based treatments for this cancer through a combined approach of network pharmacology and molecular docking.

Seneha Santoshi, Aastha Tanwar, Riddhi Bahri et al. · 0 citations
Open access Sep 2026

Taxonomy-Guided Discovery of Antiviral Resources in Korean Peucedanum L. (Apiaceae)

The genus Peucedanum (Apiaceae) contains diverse coumarins and related secondary metabolites with a wide range of pharmacological activities; however, the antiviral potential of Korean taxa remains largely unexplored. In this study, we evaluated the cytotoxicity and anti-influenza activity of aerial-part extracts from...

Gun Lee, Kyeonghee Kim, Seung Mok Ryu et al. · 0 citations
Open access Oct 2026

Exploration of the mechanisms and active compounds of Scutellaria barbata D. Don against influenza A (H1N1) virus

Scutellaria barbata D. Don ( S. barbata ), a traditional Chinese medicinal herb widely used for its heat-clearing and detoxifying properties, has shown broad-spectrum antiviral potential. However, its anti-H1N1 activity and underlying mechanisms remain to be fully elucidated. In this study, the anti...

Ying Yang, Jun-Jing Shao, Lin Hou et al. · 0 citations
Open access Sep 2026

Antiplasmodial Potential of Compounds from the Bark of Mitragyna inermis (Rubiaceae): In Silico and In Vitro Studies Against LDH, PKG Enzymes and 3D7/Dd2 Strains

Background: Plasmodium falciparum, the most virulent malaria parasite, continues to develop resistance to available drugs. Mitragyna inermis (Rubiaceae) is traditionally used in Africa for the treatment of malaria and has shown antiplasmodial activity against P. falciparum. Previous studies on this plant and related sp...

Adelphe Dounia, J. Nyemb, Roméo Toko Feunaing et al. · 0 citations
Sep 2026

Drimane-type sesquiterpenoids from aspergillus keveioides under OSMAC strategy characterized by GNPS possess in vitro antitumor cytotoxicity: A combined approach of bioactivity assay and network pharmacology.

Guided by LC-MS/MS and Global Natural Products Social Molecular Networking (GNPS), two new drimane-type sesquiterpenoids, ustusolates H and I, along with eleven known analogues, were isolated from the fermentation broth of Aspergillus keveioides. Their chemical structures were elucidated on the basis of comprehensive s...

T. Qu, Chang-Cheng Zhu, Ling-Yu Fang et al. · 0 citations
Open access Sep 2026

Dual-target chemical profiling of anti-influenza multi-components from Isatidis Radix via direct binding to neuraminidase and hemagglutinin.

Isatidis Radix, the root of Isatis indigotica, is a traditional Chinese medicine used against influenza. However, its chemical profile responsible for direct anti-influenza activity remains poorly characterized. This present study aims to classify the anti-influenza constituents of Isatidis Radix and to investigate the...

Yan Chen, Zhao Yang, Ping Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.